Yan Gao is an accomplished scientist with extensive experience in pharmacology and cancer biology. They earned a Ph.D. in Tumor Pharmacology from the Shanghai Institute of Material Medica and have held various notable positions, including Associate Principal Scientist at Merck since 2022 and prior roles at Acceleron Pharma, Novartis Institutes for BioMedical Research, and the Dana-Farber Cancer Institute. Gao's research includes significant contributions to in vivo pharmacology, specifically in chronic kidney disease and cancer biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices